Examination of oral tissue lining the mouth to measure the molecular changes that cause lung cancer can save patients and people at risk of developing lung cancer from uncomfortable procedures used now, said the team of researchers.

Mao's team, wanted to find a way to monitor patients who use one drug, COX-2 inhibitor celecoxib, sold by Pfizer (PFE.N) under the name Celebrex, hoping to prevent lung cancer.
They studied two genes, known to help prevent cancer development, p16 and FHIT. There are fundamental damage (in both genes) long before the cancer struck, "said Mao.
When speaking at the meeting of the American Association for Research Center in San Diego, they said they were seeking special damages in both of these genes in lung samples and mouth of 125 older smokers.
"We talked about just checking in to obtain the same information that we get from brushing lungs obtained through bronchoscopy,"said study presenter Dr. Manisha Bhutani who worked with Mao.
The team examined the oral tissues and the lung lining called the epithelium, in 125 chronic smokers enrolled in the study. The status of two important genes that suppress tumors analyzed. Gene, p16 and FHIT, are known to damage very early in the process of cancer development.
0 comments:
Post a Comment